These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21055512)

  • 1. Factor V Leiden mutation and pregnancy-related complications.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Am J Obstet Gynecol; 2010 Nov; 203(5):469.e1-8. PubMed ID: 21055512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy.
    Ogunyemi D; Cuellar F; Ku W; Arkel Y
    Am J Perinatol; 2003 Jan; 20(1):17-24. PubMed ID: 12638077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
    Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
    Tormene D; Grandone E; De Stefano V; Tosetto A; Palareti G; Margaglione M; Castaman G; Rossi E; Ciminello A; Valdrè L; Legnani C; Tiscia GL; Bafunno V; Carraro S; Rodeghiero F; Simioni P
    Thromb Haemost; 2012 Mar; 107(3):477-84. PubMed ID: 22273731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
    Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for pregnancy associated venous thromboembolism.
    McColl MD; Ramsay JE; Tait RC; Walker ID; McCall F; Conkie JA; Carty MJ; Greer IA
    Thromb Haemost; 1997 Oct; 78(4):1183-8. PubMed ID: 9364982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and fetal thrombophilia in intrauterine growth restriction in the presence or absence of maternal hypertensive disease.
    Pileri P; Franchi F; Cetin I; Mandò C; Antonazzo P; Ibrahim B; Rossi F; Biguzzi E
    Reprod Sci; 2010 Sep; 17(9):844-8. PubMed ID: 20601540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
    Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss.
    Ivanov PD; Komsa-Penkova RS; Konova EI; Kovacheva KS; Simeonova MN; Popov JD
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):134-40. PubMed ID: 19786941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies.
    Eroglu A; Sertkaya Karasoy D; Eroglu N; Akar N
    J BUON; 2008; 13(1):61-4. PubMed ID: 18404788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Herman M; Djelmis J; Troselj Z; Ivanisević M
    Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.